Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure

Many second-line therapies are recently approved for patients with advanced hepatocellular carcinoma (HCC), in whom protein malnutrition is prevalent that would affect treatment outcomes. In this study, we aimed to investigate the role of pre-sarcopenia and muscle restoration in patients with sorafe...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Cheng, Tsung-Yi, Lee, Pei-Chang, Chen, Yi-Tzen, Chao, Yee, Hou, Ming-Chih, Huang, Yi-Hsiang
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7591538/
https://ncbi.nlm.nih.gov/pubmed/33110117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-75198-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items